Return to homepagePandemic Pact

Enhancing the Unit Support of Uganda's Efforts to Contain COVID-19

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:5 publications

Grant number: MC_PC_20010

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $1,998,529.92

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Dr. Jonas Lexow

  • Research Location

    Uganda

  • Lead Research Institution

    MRC/UVRI and LSHTM Research Unit Uganda

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This award is being made to allow the Unit to support Uganda's efforts to contain COVID-19 through enhanced diagnostic support and testing capacity, re-deployment of Unit staff to the effort of sample collection and survey activities as well as clinical and procurement support.

Publicationslinked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules.

Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission.

SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda.

Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study.

Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.